Siemens Gets FDA Marketing Clearance of the Xprecia Stride Coagulation Analyze Device

Siemens has received 510(k) clearance from the FDA for a hand-held portable coagulation analyzer.

The device uses fresh capillary whole blood, and results are expressed as an INR (international normalized ratio).

The Xprecia Stride device is the first point-of-care/INR device cleared by the FDA that meets the new rules published in March 2016. — Cynthia Jessup